A Pharma Exec’s Inside View Of PCORI: Pfizer’s Freda Lewis-Hall
This article was originally published in The Pink Sheet Daily
Pfizer Chief Medical Officer Freda Lewis-Hall, a member of the Patient-Centered Outcomes Research Institute’s Board of Governors, talked to “The Pink Sheet” DAILY about the institute’s work over the past two years and coming up in 2013 and how the institute and the pharmaceutical industry have interacted since PCORI was set up by the Affordable Care Act.
You may also be interested in...
A senior Pfizer executive pushes the theme of large collaborations by stakeholders globally to spur innovation and productivity.
In a departure from asking researchers to propose specific research topics within broadly defined areas, the board of the Patient-Centered Outcomes Research Institute approved a plan to fund research in three targeted areas – treatment of uterine fibroids, management of asthma in African-Americans and prevention of falls in the elderly – and up to two additional areas.
Food safety programs would get the largest increase in the White House’s proposed fiscal 2015 FDA budget, and increases in user fee programs are proposed as key drivers for the boost. The agency’s overall budget would grow $335 million to $4.7 billion in the proposal.